To evaluate whether BAIBA is involved in all these spectra of metabolic disturbances in humans, additional population studies will be required comparing BAIBA plasma concentration and AGXT2 functional SNPs with severity of atherosclerosis, obesity, diabetes, and metabolic and inflammatory plasma markers. This evidence concerns the gene AGXT2 and obesity disorder.